What I get out of this article is. I, like John Paulson want to see LTS pps to improve.I wish we had an advocate like him,who could put some heat under the Boards a$$! As far as bidding $115million on a buyout,PLEASE!To get the cash they would dilute us again(give me a break)The LTS cap is only $245million(a small player.When LTS shares fall far enough(lets say $1.00)they may be taken out For starters I say,cut independent brokers commision to 75% for a year,to evaluate LTS viability.Sharpen your pencils managers.
i disagree in the statement that management is a joke.... Mr. Lampen was highlighted in IA top 25 of 2012 and that makes him very competent in my eyes...however i would like to see the board, mr lampen, and other insiders take a more focused effort in the stockholders by initiating a conference call, forward guidance, actual consistent profits on this business model because it is designed to be a cash machine, it is now a full year since they announced the acquisition of securities america and that needs to be showing the profit as well as the growth it as already inflected in the numbers. But the main thing is Dr Frost in my opinion...if the ticker doesn't have OPK in it he seems disinterested lately,,,now dont get me wrong he owns a ton of LTS but financials trade different than biotechs and when you do what you have done for OPK it would benefit us all..... I would love for him to be as involved with buying shares of LTS as he has OPK we would be over $5 now. Second... missing out on purchasing the Hartfords sale of Woodbury in my opinion was a missed opportunity for LTS to really make a splash again....but Mr Lampen will have to explain that ...well... if one calls he may explain it if he cares too... i myself am writing them a email to find out why.